Serina Therapeutics, Inc.
Cash Flow Statement
| Line Item | Jun 2026 | Mar 2026 | Sep 2025 | Jun 2025 | Mar 2025 | Sep 2024 | Jun 2024 | Mar 2024 |
|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||
| Net Income | $-6.4M | $-6.9M | $-4.6M | $-6.4M | $-4.8M | $1.4M | $5.2M | $-15.0M |
| Depreciation & Amortization | — | $0 | — | — | $0 | — | — | $25.0K |
| Depreciation | — | — | $0 | $0 | — | $0 | $0 | $23.0K |
| Amortization | — | — | — | — | — | — | $33.0K | $2.0K |
| Stock-Based Compensation | — | — | — | — | $956.0K | — | — | $53.0K |
| Net Cash from Operating Activities | $-6.7M | $-4.6M | $-3.9M | $-3.8M | $-4.3M | $-3.0M | $-8.0M | $-1.6M |
| Investing Activities | ||||||||
| Capital Expenditures | $28.0K | $25.0K | $13.0K | $46.0K | $0 | $3.0K | $0 | $14.0K |
| Business Acquisitions | — | — | — | — | — | — | — | — |
| Net Cash from Investing Activities | — | $-25.0K | — | — | $0 | — | — | $-14.0K |
| Financing Activities | ||||||||
| Dividends Paid | — | — | — | — | — | — | — | — |
| Stock Repurchases | — | — | — | — | — | — | — | — |
| Net Cash from Financing Activities | — | $26.1M | — | — | $4.9M | — | — | $2.7M |
| Net Change in Cash | — | $21.5M | — | — | $595.0K | — | — | $1.1M |
| Free Cash Flow | $-6.7M | $-4.6M | $-3.9M | $-3.8M | $-4.3M | $-3.0M | $-8.0M | $-1.6M |